Title:
II型糖尿病を治療又は予防するためのインターロイキン1受容体アンタゴニスト及び/又はピロリジンジチオカルバメートの使用
Document Type and Number:
Japanese Patent JP2005534677
Kind Code:
A
Abstract:
Substances that inhibit the action of the members of the IL-1beta/NF-kappaB pathway can be used for protecting and preserving beta-cell mass and function in prediabetic and diabetic type 2 patients. Specifically, the present invention relates to the use of an Interleukin 1 receptor antagonist (IL-1Ra) and/or pyrrolidinedithiocarbamate (PDTC) for the treatment or prophylaxis of type 2 diabetes, as well as a method for the treatment of type 2 diabetes.
Inventors:
Donas and Marc
Application Number:
JP2004516668A
Publication Date:
November 17, 2005
Filing Date:
June 25, 2003
Export Citation:
Assignee:
University of Zurich
International Classes:
A61K45/00; A61K31/40; A61K38/00; A61K38/17; A61K38/20; A61P3/10; B01J8/04; B01J19/26; C01B3/36; C01B3/38; C01B3/58; C07K14/715; H01M8/04; H01M8/06; (IPC1-7): A61K45/00; A61K31/40; A61K38/00; A61P3/10
Domestic Patent References:
| JP2001231578A | 2001-08-28 |
Foreign References:
| WO2000005234A1 | 2000-02-03 |
Attorney, Agent or Firm:
Takehiko Suzue
Satoshi Kono
Makoto Nakamura
Kurata Masatoshi
Takashi Mine
Yoshihiro Fukuhara
Sadao Muramatsu
Ryo Hashimoto
Satoshi Kono
Makoto Nakamura
Kurata Masatoshi
Takashi Mine
Yoshihiro Fukuhara
Sadao Muramatsu
Ryo Hashimoto